Clinical Trial Update: A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck [Phase 2]

View source ↗

Summary

A phase 2 randomized, double-blind trial evaluating fucoidan for efficacy and safety in patients with squamous cell carcinomas of the head and neck.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Fucoidan (fucoidan)

Snippet

Sponsor: Hi-Q Marine Biotech International, Ltd. | Conditions: Squamous Cell Carcinomas of the Head and Neck | Phase 2 | Status: UNKNOWN